secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMARIN CORP PLCUK (AMRN)
CIK:        0000897448
Form:       8-K
Filed at:   2026-07-29T20:30:15+00:00
Accession:  0001193125-26-323841
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amarin Q2 2026 net revenue $42.2M (-42% YoY); operating loss narrows to $12.0M; cash grows to $314.6M
--------------------------------------------------------------------------------

- Total net revenue $42.2M, down 42% YoY due to absence of $25M Recordati upfront payment and generic pressure on U.S. VASCEPA pricing.
- Operating expenses fell 59% to $27.0M; excluding restructuring, down 38% YoY, completing $70M annual cost savings initiative.
- Operating loss improved to $12.0M from $16.0M; net loss $7.7M vs $14.1M; cash grew to $314.6M, debt-free.
- Global in-market demand for VASCEPA/VAZKEPA rose 59% YoY; U.S. IPE market share increased to 48% from 43%.
- Company expects continued international growth, consistent U.S. volumes, and ~10% cash growth by year-end 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/897448/000119312526323841/0001193125-26-323841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/897448/000119312526323841/amrn-20260729.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-323841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer